Comparative efficacy of hydroxyethyl starch and haemaccel in the treatment of severe ovarian hyperstimulation syndrome.
Schimetta
Wolfgang
W
Laubenthal
Heinz
H
Sirtl
Clemens J
CJ
D005260:Female; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use*; D016471:Ovarian Hyperstimulation Syndrome / Q000188:drug therapy*; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011097:Polygeline / Q000627:therapeutic use*
D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes; D011097:Polygeline